NEW YORK (GenomeWeb) – Johnson & Johnson affiliate Janssen Pharmaceutica announced today that its Ebola assay has been granted Emergency Use Authorization by the US Food and Drug Administration.

The Ebola Virus Triage Test, performed on the Biocartis Idylla platform, is a closed-tube real-time reverse transcription PCR test for qualitative detection of the virus in samples of whole blood. The automated test does not require cold chain storage, runs in 100 minutes, and requires minimal training to interpret results, Janssen noted in a statement. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.